What is Immunome's capex?

Immunome (IMNM) reported capex of $3M in Q1 2026.

How has Immunome's capex changed year-over-year?

Immunome's capex decreased by 18.1% year-over-year, from $3.67M to $3M.

What is the long-term trend for Immunome's capex?

Over 4 years (2021 to 2025), Immunome's capex has grown at a 232.8% compound annual growth rate (CAGR), from $79K to $9.69M.

What does capex mean?

Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.

Immunome IMNM CapEx

CapEx at other companies

PfizerPFE

$436M-22.7%

Arcus BiosciencesRCUS

$0-100%

Nuvation BioNUVB

$48K-33.3%

IDEAYA Biosciences, Inc.IDYA

$967K-27.3%

ImmunityBio, Inc.IBRX

$1.78M+58.4%

Summit TherapeuticsSMMT

$245K-41.9%

Other financials

Income statement

See full

Revenue--100%

Operating income-$59.3M-32.9%

Net income-$53.8M-29.3%

EPS (diluted)-$0.48+7.7%

Balance sheet

See full

Cash & equivalents$582.7M+126%

Total debt$3.7M-22.6%

Total equity$588.7M+91.7%

Total assets$619.8M+80.9%

Cash flow

See full

Operating cash flow-$58.6M-10.5%

Free cash flow-$61.6M-8.7%

Valuation

See full

Market cap$2.19B+323%

Enterprise value$1.61B+470%

P/S545.2×+498×

Profitability

See full

Operating margin-5,947.9%-12,002pp

Net margin-5,593.8%-11,284pp

FCF margin-5,118.9%-8,601pp

Returns & leverage

See full

Return on equity-50.1%-10.8pp

Debt / equity0×0.0×

Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Immunome’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunome's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Immunome's capex?: Immunome (IMNM) reported capex of $3M in Q1 2026.
How has Immunome's capex changed year-over-year?: Immunome's capex decreased by 18.1% year-over-year, from $3.67M to $3M.
What is the long-term trend for Immunome's capex?: Over 4 years (2021 to 2025), Immunome's capex has grown at a 232.8% compound annual growth rate (CAGR), from $79K to $9.69M.
What does capex mean?: Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.